Viriom, Inc. announced the initiation of a Phase 2 clinical study to evaluate the efficacy of elsulfavirine in adults with moderate manifestations of COVID-19 (novel coronavirus).

Last week, our team had the incredible opportunity to attend the Annual Meeting of the American Association for Cancer Research (AACR) in San Diego.

Excited for AACR 2024, we invite you to meet our executive team, led by CEO Bill Farley.

Last week, our ChemDiv team, Michael Nyman, Roman Timakhov, and Aleksandra Khotimchenko, had the incredible opportunity to attend the Drug Discovery Chemistry conference in sunny San Diego.

We're thrilled to announce that our team members, Roman Timakhov and Aleksandra Khotimchenko, will be attending the Drug Discovery Chemistry in San Diego, April 1-4.